These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7126630)

  • 1. A protein activator of galactosylceramide beta-galactosidase.
    Wenger DA; Sattler M; Roth S
    Biochim Biophys Acta; 1982 Sep; 712(3):639-49. PubMed ID: 7126630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity of galactosylceramidase activation by phosphatidylserine.
    Hanada E; Suzuki K
    Biochim Biophys Acta; 1980 Aug; 619(2):396-402. PubMed ID: 6773584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical pathology of krabbe's disease. IV. Studies of galactosylceramide and lactosylceramide BETA-galactosidases in brain, white blood cells and aminotic fluid cells.
    Svennerholm L; Häkansson G; Vanier MT
    Acta Paediatr Scand; 1975 Jul; 64(4):649-56. PubMed ID: 1155085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human brain cerebroside beta-galactosidase: deficiency of transgalactosidic activity in Krabbe's disease.
    Carter TP; Beblowski DW; Savage MH; Kanfer JN
    J Neurochem; 1980 Jan; 34(1):189-96. PubMed ID: 6778958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrolysis of galactosylceramide is catalyzed by two genetically distinct acid beta-galactosidases.
    Kobayashi T; Shinnoh N; Goto I; Kuroiwa Y
    J Biol Chem; 1985 Dec; 260(28):14982-7. PubMed ID: 3934152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and properties of a heat-stable glucocerebrosidase activating factor from control and Gaucher spleen.
    Peters SP; Coyle P; Coffee CJ; Glew RH
    J Biol Chem; 1977 Jan; 252(2):563-73. PubMed ID: 13071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoelectric focusing of galactosylceramide beta-galactosylceramide beta-galactosidase in cultured skin fibroblasts of patients with Krabbe's globoid-cell leucodystrophy.
    Besley GT
    Biochem Soc Trans; 1975; 3(2):241-4. PubMed ID: 1132549
    [No Abstract]   [Full Text] [Related]  

  • 8. Hydrolysis of lactosylceramide by human galactosylceramidase and GM1-beta-galactosidase in a detergent-free system and its stimulation by sphingolipid activator proteins, sap-B and sap-C. Activator proteins stimulate lactosylceramide hydrolysis.
    Zschoche A; Fürst W; Schwarzmann G; Sanhoff K
    Eur J Biochem; 1994 May; 222(1):83-90. PubMed ID: 8200356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the properties and bile salt specificities of galactosylceramide and lactosyl ceramide beta-galactosidase activities in human leucocytes and fibroblasts.
    Poulos A; Beckman K
    Clin Chim Acta; 1980 Feb; 101(2-3):277-85. PubMed ID: 6766828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrolysis of galactosylsphingosine and lactosylsphingosine by beta-galactosidases in human brain and cultured fibroblasts.
    Goda S; Kobayashi T; Goto I
    Biochim Biophys Acta; 1987 Aug; 920(3):259-65. PubMed ID: 3111543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A taurodeoxycholate-activated galactosylceramidase in the murine intestine.
    Kobayashi T; Suzuki K
    J Biol Chem; 1981 Feb; 256(3):1133-7. PubMed ID: 7451495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and properties of galactosylceramide sulfatase activator from human liver.
    Mitsuyama T; Gasa S; Nojima T; Taniguchi N; Makita A
    J Biochem; 1985 Sep; 98(3):605-13. PubMed ID: 4086463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of bile salts on lactosylceramide beta-galactosidase activities in human brain, liver and cultured skin fibroblasts.
    da Wenger ; Sattler M; Clark C
    Biochim Biophys Acta; 1975 Dec; 409(3):297-303. PubMed ID: 812551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Krabbe's globoid cell leucodystrophy. Studies on galactosylceramide beta-galactosidase and non-specific beta-galactosidase of leucocytes, cultured skin fibroblasts, and amniotic fluid cells.
    Besley GT; Bain AD
    J Med Genet; 1976 Jun; 13(3):195-9. PubMed ID: 819652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of GM1 ganglioside beta-galactosidase from normal feline liver and brain.
    Anderson JK; Mole JE; Baker HJ
    Biochemistry; 1978 Feb; 17(3):467-73. PubMed ID: 413573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The specificity of beta-galactosidase in the degradation of gangliosides.
    Suzuki K; Tanaka H; Yamanaka T; Van Damme O
    Adv Exp Med Biol; 1980; 125():307-18. PubMed ID: 6767344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of human hepatic beta-galactosidase toward natural glycosphingolipid substrates.
    Tanaka H; Meisler M; Suzuki K
    Biochim Biophys Acta; 1975 Sep; 398(3):452-63. PubMed ID: 1174525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antenatal diagnosis of Krabbe's leucodystrophy: enzymatic and morphological confirmation in an affected fetus.
    Farrell DF; Sumi SM; Scott CR; Rice G
    J Neurol Neurosurg Psychiatry; 1978 Jan; 41(1):76-82. PubMed ID: 621534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substrate specificities of the two genetically distinct human brain beta-galactosidases.
    Tanaka H; Suzuki K
    Brain Res; 1977 Feb; 122(2):325-35. PubMed ID: 13910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morquio disease, type B: activation of GM1-beta-galactosidase by GM1-activator protein.
    Paschke E; Kresse H
    Biochem Biophys Res Commun; 1982 Nov; 109(2):568-75. PubMed ID: 6817758
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.